Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient
    119.
    发明授权
    Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient 有权
    具有特定晶体习性的结晶形式和含有该结晶形式作为活性成分的药物组合物

    公开(公告)号:US09453006B2

    公开(公告)日:2016-09-27

    申请号:US14388218

    申请日:2013-06-24

    IPC分类号: C07D409/06

    CPC分类号: C07D409/06

    摘要: Means for improving the solubility of luliconazole is provided. A crystal of luliconazole represented by the following formula is provided, wherein the crystal has such a crystal habit that (011) plane is a specific crystal growth plane. The crystal is characterized in that I(011) with respect to a sum total of I(001), I(100), I(10-1), I(011), I(110), I(11-1), I(10-2), I(11-2), I(020), I(021), I(20-2), I(121), I(013), I(11-3), and I(221) is not less than 25%, provided that integrated intensities of diffraction peaks, which correspond to the (001), (100), (10-1), (011), (110), (11-1), (10-2), (11-2), (020), (021), (20-2), (121), (013), (11-3), and (221) planes, are designated as I(001), I(100), I(10-1), I(011), I(110), I(11-1), I(10-2), I(11-2), I(020), I(021), I(20-2), I(121), I(013), I(11-3), and I(221) respectively in relation to the diffraction peaks detected in a range of 2θ=5 to 35° in a powder X-ray diffractometry using CuKα radiation.

    PHARMACEUTICAL COMPOSITION FOR DISEASES CAUSED BY PATHOGENIC MICROORGANISMS SUCH AS ASPERGILLUS
    120.
    发明申请
    PHARMACEUTICAL COMPOSITION FOR DISEASES CAUSED BY PATHOGENIC MICROORGANISMS SUCH AS ASPERGILLUS 审中-公开
    致病微生物如ASPERGILLUS引起的疾病药物组合物

    公开(公告)号:US20150366845A1

    公开(公告)日:2015-12-24

    申请号:US14760917

    申请日:2013-12-27

    IPC分类号: A61K31/4178

    CPC分类号: A61K31/4178 A61K9/2866

    摘要: An object is to provide means for precisely treating pneumonia caused by intracellular parasite, protozoa, and/or fungus. A pharmaceutical composition for pneumonia, comprising a compound represented by the following general formula (1) as an active ingredient: (In the formula, R represents a halogen atom or a hydrogen atom, and X represents a halogen atom.)

    摘要翻译: 目的是提供精确治疗由细胞内寄生虫,原生动物和/或真菌引起的肺炎的手段。 一种肺炎药物组合物,其特征在于,含有下述通式(1)表示的化合物作为有效成分:(式中,R表示卤原子或氢原子,X表示卤素原子)